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Abstract
Background: The assessment of a new health technology is a multidisciplinary and multidimensional process,
which requires a complex analysis and the convergence of different stakeholders into a common decision. This
task is even more delicate when the assessment is carried out in early stage of development processes, when the
maturity of the technology prevents conducting a large scale trials to evaluate the cost effectiveness through
classic health economics methods. This lack of information may limit the future development and deployment in
the clinical practice. This work aims to 1) identify the most relevant user needs of a new medical technology for
managing and monitoring Parkinson’s Disease (PD) patients and to 2) use these user needs for a preliminary
assessment of a specific system called PERFORM, as a case study.
Methods: Analytic Hierarchy Process (AHP) was used to design a hierarchy of 17 needs, grouped into 5 categories.
A total of 16 experts, 6 of them with a clinical background and the remaining 10 with a technical background,
were asked to rank these needs and categories.
Results: On/Off fluctuations detection, Increase wearability acceptance, and Increase self-management support have
been identified as the most relevant user needs. No significant differences were found between the clinician and
technical groups. These results have been used to evaluate the PERFORM system and to identify future areas of
improvement.
Conclusions: First of all, the AHP contributed to the elaboration of a unified hierarchy, integrating the needs of a
variety of stakeholders, promoting the discussion and the agreement into a common framework of evaluation.
Moreover, the AHP effectively supported the user need elicitation as well as the assignment of different weights
and priorities to each need and, consequently, it helped to define a framework for the assessment of telehealth
systems for PD management and monitoring. This framework can be used to support the decision-making process
for the adoption of new technologies in PD.
Background
Parkinson’s disease (PD) is a neurodegenerative disorder
affecting more than 1% of people older than 60 years
(and with an increased prevalence in older subjects). As
other chronic diseases, PD is a prolonged condition that
does not improve with time and cannot be cured com-
pletely. Progression of the disease is strongly correlated
with higher costs - for both patients and healthcare
institutions - and substantial savings can be achieved by
slowing down this progression [1].
Telemedicine could contribute to optimize the use of
health services in PD management by delivering care ser-
vices in daily living environments and strengthening the
connection between patients and care providers. This
would result in improved level of care measured through
target indicators like number and quality of visits, access to
emergency departments and ambulance services, number
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of hospitalizations, hospital readmissions, and length of
hospital stay, number of referrals, duration of consulta-
tions, number of laboratory tests, and avoided transfers/
evacuations [2,3]. Yet, there is a widespread perception
that telemedicine applications are not as widely used as
expected. The limited availability of information on
large-scale performance and economic impact might
account for some of these perceptions [4,5]. This is par-
ticularly relevant in the case of PD, where no large scale
pilots have been conducted in order to address these
issues, as most validations are limited in number of sub-
jects and are focused on the assessment of the technical
feasibility and clinical outcomes [6].
To estimate the economic benefits of telemedicine pro-
grams, clinical and social outcomes must be translated
into monetary values using reliable conversion factors, but
before that, it should be verified that the technology prop-
erly satisfies user needs. This step is problematic and com-
plex in healthcare, which by nature is a multidisciplinary
area involving multidimensional data sources and stake-
holders. Designers and developers of a new technology
have, in general terms, a more advanced knowledge in the
technological field than the final users. Therefore, it is fun-
damental to elicit end-users perspectives during the design
process, and take them into account for the assessment of
the technology once it is developed and tested.
Additionally, different aspects and factors may affect the
user needs and the problem definition: medical goals are
often driven by contingencies, they change according to
the scale of the problem, and therefore it is not easy to
identify a gold standard method. Although many authors
suggest to assess the effects of technology-based health-
care interventions by grouping them in several dimensions
(economical, technical, ethical, etc.), the majority of studies
are focused mainly on two of them, the clinical and the
economical ones [6].
It is widely accepted that medical devices, or in general
health technologies can be used only if they cover the
needs of end-users [7]; achieving this goal can be com-
plex and challenging: identical requirements (e.g. safety,
efficacy) can be evaluated differently for the same tech-
nology and technique, depending on the clinical problem,
the medical and organizational skills and procedures of a
practice team, on patient’s attitudes and health status
[8,9]. Even within apparently homogeneous user groups,
individuals may have received different training and
working guidelines. Opinions from different stakeholders
must be collected, considered and balanced according to
the differences and conflicts that may arise. This issue is
relevant for professionals involved in decision making
processes related with the design, production, evaluation
and purchase of medical devices [9]. As a matter of fact,
the healthcare industry has been increasingly adopting
and making use of user needs elicitation methods and
seeking for quantified and objective information to define
plans and strategies for improving their service/product
portfolios and reduce their market risks [10].
Nevertheless, the lack of time and/or resources, as well
as the lack of knowledge about appropriate methods for
data collection and analysis could compromise the elici-
tation of requirements [11,12], resulting in information
base that could be fragmented, partial, inconsistent, not
meaningful and as such, not enough to answer the
desired questions [9,13].
This research work aims at identifying and ranking the
key user needs that a telehealth system for the manage-
ment of Parkinson’s disease should cover, in order to be
useful and effective. Additionally to the identification, a
quantitative evaluation of the importance of each need
compared to the others is provided. The Analytic Hier-
archy Process (AHP) was chosen to perform this work.
This methodology has been already used in healthcare,
with different goals and objectives, such as user needs
elicitation [9,14,15], medical decision-making [16],
budget allocation [17] and medical device purchasing
[18]. A group of experts was involved to identify and
prioritize these needs. Two types of expertise have been
required as inclusion criteria for the expert selection.
On the one hand, participants with a clinical back-
ground, and with experience and knowledge of the
eHealth field; on the other hand, participants with a
technical background as well as experience in the design
and development of telehealth and/or eHealth systems.
In both cases, the selection of the participants required
at least a basic knowledge of the Parkinson’s disease
symptoms and progression. The analysis of the results
allowed to identify, rank and quantify the views
from both technical and clinical experts, and finally, to
understand in which cases their opinion is similar and
in which cases there are discrepancies in their points
of view.
As a case study, the results this process have been used
for the assessment a telehealth system for Parkinson’s
disease management called PERFORM [19].
Parkinson’s disease
PD is a disorder largely caused by the loss of dopami-
nergic innervation of the basal ganglia, resulting in
motor disturbances such as slowed movement (bradyki-
nesia), small amplitude movements (hypokinesia), rest-
ing tremor, postural instability and rigidity.
These problems often restrict functional independence
and are a major cause of morbidity and mortality
among these patients [20-23]. PD is typically character-
ized by severe, unpredictable and abrupt changes in the
patient motor performance whereby OFF periods, char-
acterized by the temporary loss of drugs effectiveness,
alternate, sometimes within minutes, with ON periods,
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during which the medication effectively attenuate
motion symptoms.
PERFORM system
PERFORM system is focused on achieving a better med-
ication adjustment in PD through a better and more
objective monitoring of the patients’ symptoms (spe-
cially through a better identification of the On-Off fluc-
tuations), reducing costs by utilizing Information and
Communication Technologies (ICT), reducing the num-
ber of unneeded transportations and optimizing the
waiting and consultation time, transferring health
knowledge from the practitioner to the patient, increas-
ing self-management capability and medication adher-
ence. The system includes a set of wearable sensors for
the continuous recording of the motion signals and a
set of software algorithms for the signal processing. The
wearable system is composed of a set of four wearable
tri-axial accelerometers placed at each patient limb
(wrists and ankles) used to seamlessly record accelera-
tion in the three spatial directions; a waist sensor, com-
posed of an accelerometer and a gyroscope; and a data
logger used to receive and store all the data in a SD
card. Data transmission from the sensors to the data
logger was done using Zigbee protocol and the sampling
rate was 62.5 Hz. All accelerometers transmit data
simultaneously and without retransmission of lost pack-
ets, in order to save battery. The system is characterized
with a global data loss of 1.24 ± 0.58% [24].
A specific software system, the Local Base Unit (LBU),
was built and installed at patients’ homes. It was respon-
sible for the automatic detection and quantification of
the patient symptoms - based on the data download
from the data logger - and the recording of other useful
information for the evaluation of the patient status. For
each symptom, a dedicated algorithm processes the rele-
vant signals, detects the symptom episode and quantifies
it into a severity scale from 0 to 4, according to the Uni-
fied Parkinson’s Disease Rating Scale (UPDRS). The
Graphical User Interface (GUI) used in the LBU was
specifically designed for PD patients, allowing them to
enter information, like medication intakes (type, dose
and time), meals (type of food, amount, time) and PDQ-
39, a standard questionnaire for the evaluation of physi-
cal, emotional and psychosocial aspects of Quality of
Life (QoL) in PD patients [25,26]. The GUI was tested
in different phases and redesigned according to the
users’ feedback [27].
Regarding the technical performance of the system, it
shows an accuracy of up to 93.73% for the classification
of levodopa induced dyskinesias (LID) severity [28], an
86% for the classification of bradykinesia severity [29]
and 87% for tremor severity [30]. Also, a specific mod-
ule was developed for the assessment of gait [31] and
for the detection of On-Off fluctuations [32] (showing
an average accuracy of 88.2% in classifying the time that
the patient spends in the different phases).
Methods
Ethical considerations
This was an interview study with experts and without
patient involvement. A participant information sheet
was presented informing about the purpose of study and
a detailed description of the tasks that they must per-
form. Participants gave informed consent to participate
in the study. The data collected was associated to the
participant profile and background in order to analyse
the results properly. The name or any other personal
detail has not be disclosed at any time.
AHP
AHP is a method for decision-making, aiming at solving
complex problems. This method allows quantifying opi-
nions and transforming them into a coherent decision
model. A hierarchy of elements, grouped into categories,
is defined through this method. Elements and categories
are then ranked, via questionnaires, through pair-wise
comparisons. Moreover, it is possible to assess the
coherence of respondent judgments and ask the experts
to refine incoherent answers. Once questionnaires are
finalized, it is possible to extract the relative importance
of each need per category (local weights, LW), the rela-
tive importance of each category (category weights,
CW), and the importance of each need compared to all
the others (Global weights, GW) [33,34].
Hierarchy definition
In order to identify the elements and categories of the
hierarchy, a literature review was performed; then a
focus group with experts was done to organize these
factors in nodes and leafs. This focus group involved 2
clinicians and 5 biomedical engineers with experience in
the design, assessment and management of medical
devices, of which 2 are co-authors of this paper (JC,
GF). JC acted as the facilitator and designed the first
version of the hierarchy, based on his own experience,
and the work of Dávalos et al. [2], who proposed a wide
range of indicators that can be used to analyse the out-
come of telemedicine systems, and how to convert them
into monetary units. Then, the hierarchy was distributed
and reviewed by the other experts. Finally, it was
updated according to the feedback received from all of
them. In the first iteration, 29 needs were identified and
organized into five meaningful categories. Then, com-
mon needs were merged, in order to avoid overlapping
and thus optimize the total number of needs. This pro-
cess has been presented in [35]. The final tree is
described in Table 1; each node represents a category,
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each leaf represents a need. It is composed of 5 cate-
gories and 17 needs.
Participants
Table 2 shows the profile of the different responders
involved in this study.
Questionnaires
Once the tree was finalized, questionnaires were prepared
to compare the relative importance of each need with all
of the other needs within the same category. For each pair
of needs, the following question was asked: “In a technolo-
gical solution for Parkinson’s disease monitoring, assess-
ment and/or management, from your point of view and
according to your experience, which is the most important
element and how much important it is with respect to the
other?”. Responders answered by choosing which one of
the options was more important, by selecting an integer
numerical value from 1 (both options are equally impor-
tant) to 9 (the selected element is much more important).
The application used for creating the hierarchy and
collecting answers is the BPMSG AHP Online System
(Available online: http://bpmsg.com/). This system auto-
matically calculates the Consistency Rate (CR) and
shows some options to improve the consistency when
the value is higher than 10%.
Grouping experts judgements
One of the aims of this work was to explore the differ-
ences between the two groups of experts. Different actions
were done to study the different perspectives of both
groups. The first one was to graphically represent the GW
of each user needs using a boxplot chart with data from all
the participants (Figure 1) and another one was to aggre-
gate the GW with the technical and clinical participants
(Figure 2). Boxplots plot the median values (central
marks), the 25th and the 75th percentiles (the blue range)
and the outliers (crosses). Then, on the different results
tables (Table 3 and Table 4) the median values of the GW,
LW and CW for each group are included in a numerical
way.
Correlations among responders’ preferences and group
consensus
In order to analyse the consistency of the responses
between the different participants, two different measures
have been used. The first one is the Spearman rank cor-
relation (r or RHO), commonly used for AHP-based stu-
dies [9,36,37], to show how much two sets of elements
are ranked in the same order [38]. The p-value was used
(p < 0.05) to identify which values should be considered
as significant.
Furthermore, the BPMSG AHP Online System automa-
tically provides a measure of consensus group (both for
the general hierarchy as well as for the responses of every
individual category), defined as a diversity index for the
distribution of priorities among criteria [39]. The diversity
index is then used to build a relative index of homogene-
ity S, which can be used as a consensus indicator; it is
zero, when the priorities are completely distinct and
unity when the priorities of all are identical.
Table 1 AHP hierarchy.
Nodes (Categories) Elements
(User needs)
Performance Motor symptoms assessment
ON/OFF fluctuations detection
Cognitive & behavioral assessment
Data mining & disease modelling
User experience ↑ wearability acceptance
User-friendly interfaces
Seamlessly integration
Clinical practice ↑ patient-clinician bond
↑ patient & carers knowledge
↑ self-management support
↑ assist care givers
Economic ↓ visits and stays in hospital
↑ patient Quality of Life
Faster and more reliable diagnosis
Technical issues Scalability and interoperability
Security and privacy
↓ maintenance and support cost
Hierarchy used for this AHP study including the categories and user needs.
Table 2 Participants profile.









1 Technical Female 26 5 26
2 Technical Male 20 11 20
3 Technical Male 8 7 8
4 Technical Male 12 6 12
5 Technical Male 7 5 6
6 Technical Male 7 5 6
7 Technical Male 10 1 8
8 Technical Male 10 2 8
9 Technical Male 5 4 5
10 Technical Male 7 5 6
11 Clinical Female 8 4 5
12 Clinical Female 12 10 4
13 Clinical Male 19 11 5
14 Clinical Male 25 25 15
15 Clinical Female 26 12 0
16 Clinical Female 4 4 2
Profile of the participants in the AHP study
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Results
Figure 3 shows the global picture of the AHP results
and Table 3 summarizes the results of the AHP ques-
tionnaire. The second column shows for each element
of the hierarchy the Global Weights (GW) and the
Local Weights (LW) resulted from the AHP analysis.
These results are based on the AHP method and take
into account the responses from all the participants.
The third and fourth columns show the median of the
GW and LW values, grouped according to the profile of
Figure 1 Boxplot with the result of all the responders. Central mark is the median, the edges of the box are the 25th and 75th percentiles,
the whiskers extend to the most extreme data points not considered outliers, and outliers are plotted individually.
Figure 2 Boxplot with the result of the responders grouped by technicians and clinicians profiles. Central mark is the median, the edges
of the box are the 25th and 75th percentiles, the whiskers extend to the most extreme data points not considered outliers, and outliers are
plotted individually.
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the responders (clinical and technical). The last column
show the t-test comparing the responses of the two
groups of responders. The information of the median
values is also provided in the Figure 1, where the box-
plots show, for each element of the hierarchy, the median
value (central mark), the 25th and the 75th percentiles.
Table 4 contains the Categorical Weights (CW) obtained
from the responses of all the participants (second column);
the third and fourth columns show the median values
obtained for the technical and clinical groups. The last
Table 3 Local and global weights of needs (CR<0.1), median of the Local and global weights for the clinical and
technical groups and t-test between the two groups.
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Table 4 Categorical weights, median of the weights for
the clinical and technical groups and t-test between the
two groups.
CW Technical Clinical t-test
1 Performance 0.219 0.207 0.200 0.375
2 User experience 0.222 0.216 0.159 0.560
3 Clinical practice 0.297 0.233 0.278 0.573
4 Economic 0.124 0.110 0.104 0.520
5 Technical issues 0.137 0.103 0.140 0.337
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column shows the t-test between the CW between clinical
and technical groups.
Table 5 shows the group consensus within each cate-
gory, within categories and integrated group consensus
based on the GW values.
Discussion
This work has two main goals: firstly, to identify the ele-
ments that a telehealth system for PD management
should fulfil in order to be effective and, secondly, to
understand if clinicians and technicians share a common
opinion when evaluating these systems.
According to the results of the responders, the three
most important user needs are Increase the wearability
acceptance (0.102), Increase the self-management support
(0.093) and On/Off fluctuations detection (0.085), based
on the values from the Global Weights (GW). In a sec-
ond level of importance we found Increase patient &
carers knowledge (0.080), Assist care givers (0.070), User-
friendly interfaces (0.068), Motor symptoms assessment
(0.064) and Increase patient Quality of Life (0.063).
The analysis of the Categorical Weights (CW) pro-
vides information about the importance of the different
categories. The Clinical Practice category has been high-
lighted as the most relevant category by all the respon-
ders (0.297), followed by the Performance and User
experience categories which scored very similarly (0.219
and 0.222). Finally, the Economic and Technical Issues
categories were the less relevant according to these
results (0.124 and 0.137). As regards the differences
Figure 3 Group results of the user needs. This chart shows the group results of the GW for each user need including the response of all the
participants.
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between the clinical and the technical groups, in both
cases the Clinical practice category has the highest rele-
vance. Performance and the User experience categories
as the following categories, while Economic and Techni-
cal issues as the less relevant ones. Nevertheless, there
are some differences: for the technical group the User
experience is the second most important category and
the Technical issues the less important; for the clinical
group it is the opposite: Performance is the second most
important, while the Economic category the less one.
However, no significant difference between the
responses of the clinical and technical groups has been
found. Regarding the GW and LW of all the elements
(Table 3), a similar scenario has been found. In this
case, the only statistically significant difference is found
in the LW of the Cognitive & behavioural modelling ele-
ment. The clinical group has rated this issue signifi-
cantly higher than the technical group. In all the other
cases, the differences are not significant. Besides, in the
clinical group the three top GW of the clinical group
match the aggregated top three GW; in the case of the
technical group, On/Off fluctuations detection, Increase
wearability acceptance, and User-friendly interfaces have
been considered as the most relevant elements. It is also
important to highlight that some of those requirements
such as wearability, usability have a huge impact, not
only on the user experience but also on the effectiveness
and safety of health technologies.
As regards the relevance of the different elements
given a specific category: in the Performance category
On/Off fluctuations detection (0.388) is the most impor-
tant element, followed by the Motor symptoms assess-
ment (0.292), Cognitive & behavioural assessment
(0.197) and Data mining & disease modelling (0.129).
Regarding the User experience category, Increasing the
wearability acceptance (0.457) is considered the most
important need, followed by User-friendly interfaces
(0.305) and Seamlessly integration (0.237). According to
these results, when working with wearable devices, the
User Experience (UX) is strongly affected by the experi-
ence of the user interacting with the physical devices.
This effect is due to not only to the physical features of
the devices (i.e. size, weight, comfort) but also to a
social component implicit in wearing a medical device
(i.e. what other people could think when I wear this
device) [40]. This issue may also be linked with the priv-
acy of the patient.
In the third category, Clinical practice, the need
Increase self-management support (0.314) obtained the
highest LW, followed by Increase patient & carers
knowledge (0.270) and Assist care givers (0.235). Finally,
Increase patient-clinician bond (0.181) scored the lowest
weight. These results reflect a clear demand in providing
both patients and carers with tools that improve the
management of the disease and increase the effective-
ness of healthcare interventions.
As regards the fourth category, Economic aspects,
Increase patient Quality of Life (0.511) is considered as the
most important element; the second one is Faster and
more reliable diagnosis (0.313), while Decreasing visits and
stays in the hospital (0.175) is considered as less impor-
tant. This last result was expected since most of the PD
patients do not suffer acute episodes requiring long stays
in the hospital. Instead, the main economic benefit could
be achieved by improving the QoL. Actually, this could
also be expected since PD has an enormous impact on the
QoL by limiting their mobility and independence. Addi-
tionally, improving in diagnosis could also generate an
economical benefit due to a most effective use of the
resources.
Finally, within the last category, Technical issues, the
Security and privacy (0.430) aspects are ranked as the
most relevant user needs, followed by Scalability and
interoperability (0.293) and Decrease maintenance and
support cost (0.277). As expected in a healthcare sce-
nario, security and privacy issues are the most relevant
needs, while other Information Technology (IT) issues
are considered as secondary.
Usually, clinical effectiveness and safety are the primary
concerns in medicine [8], in this case, the impact of a tele-
health system for disease management and monitoring in
the safety of the patient is very limited and this fact is
reflected in the opinion of the experts that did not include
these issues among the most relevant ones.
Additionally to the t-test performed between the med-
ian values for the CW, GW and LW calculated for the
clinical and technical groups, the Spearman correlation
(r) and the associated p-value (p) were also calculated
taking into consideration the median values of the
GW for the clinical and technical groups. This measure
is intended to quantify the similarity between the
responses of both groups. The result is r = 0.590 (p =
0.012): we can conclude that there is a significant corre-
lation between both groups. This fact is reinforced by
the measures of the group consensus on Table 5. These
values show a high degree of consensus between all the
Table 5 Group consensus.
Group consensus
1 Performance elements 0.720
2 User experience elements 0.867
3 Clinical practice elements 0.773
4 Economic elements 0.762
5 Technical issues elements 0.784
Between categories elements 0.709
AHP Group consensus (rel. homogeneity ) 0.736 (0.734)
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participants, especially within the elements of the User
experience category (0.867).
Evaluation of the PERFORM system
In additional file 1, Table S1, a description of the user
needs identified in the AHP and to which extent the
PERFOM fulfils them is given. This way, it is possible to
evaluate the PERFORM system by understanding if the
system complies with each needs and estimating its
importance, weighted according to the GW of each need.
As regards the most relevant elements, On/Off fluc-
tuations detection, Increase wearability acceptance,
Increase patient & carers knowledge and Increase self-
management support, it is possible to appreciate that the
PERFORM system fulfilled reasonably the On/Off fluc-
tuations detection and Increase wearability acceptance.
It partially complies with the Increase self-management
support. Nevertheless, it failed in reaching the Increase
patient & carers knowledge element: even though the
system provides enough information about patients’
symptoms and their evolution, it does not give support
in understanding their own status. According to the
experts, it is not enough to monitor and assess the
patient seamlessly but it is also crucial to advise and
guide him/her, by customizing and personalizing guide-
lines according to the current status that the system
allows to assess. Another important issue where PER-
FORM fails and that it was highlighted as important, is
to assist care givers. According to the experts consulted
in the study, the role of caregivers is remarkably impor-
tant - this stakeholder is also included in the Increase
patient & carers knowledge - and was not considered in
the current version of the system.
Moreover, PERFORM did not incorporate the moni-
toring of no-motor systems, being especially relevant the
Cognitive & behavioral assessment one. The incorpora-
tion of these user needs and the jointly assessment of
motor and cognitive components would significantly
enrich and benefit the modeling of the disease according
to the experts’ opinion.
Conclusions
First of all, AHP contributed to the elaboration of a com-
mon hierarchy, integrating user needs from different sta-
keholders and promoting the discussion and the
agreement into a common framework. Moreover, AHP
effectively supported the user need elicitation as well as
the assignment of different weights and priorities to each
need and consequently, it helped in the elaboration of
common framework of assessment of telehealth systems
for PD management and monitoring. It has been used to
clearly identify the key user needs that a telehealth
system for the remote monitoring and management of
PD should fulfil, specifically, the On/Off fluctuations
detection, Increase wearability acceptance, Increase
self-management support and Increase self-management
support have been identified as the most relevant by a
group of clinicians and engineers with experience in the
field.
Thus, this work offers a validated framework of
evaluation for researchers and developers working in the
field of telehealth for PD management and assessment a
useful tool for the identification of improvement areas.
In the case of the PERFORM system three areas of
future improvement were identified: 1) the involvement
of the carers in the loop was strongly recommended
according to the AHP results, 2) the telehealth system
and the information from the monitoring and assess-
ment should be used to educate and feedback patient
and carers according to their specific needs in order to
make the platform actually useful and 3) the incorpora-
tion of cognitive and behavioral analysis to the motor
assessment may significantly enhance the modeling of
the disease. These elements have been considered for
the design of a new research project, the PD Manager
project (http://www.parkinson-manager.eu/), in which
the role of the caregivers, behavioural and cognitive
monitoring and patient education have been included as
important pillars for a new generation of mHealth
services for Parkinson disease. A second conclusion is
that no significant differences were found between the
clinician and technical groups. Moreover, AHP proved
to be a useful tool to improve the communication and
promote the discussion among the different stakeholders
and the different professionals involved in the design of
telehealth systems. In this case a clear agreement
between both groups were found and only one of the
seventeen user needs show a slight discrepancy between
these groups (only at a LW level). Moreover, the high
levels of correlation within the answers and of group
consensus confirm that this framework could be useful
for future evaluation of technologies in PD and thus
support the decision-making process in their adoption.
Additional material
Additional file 1: Table S1, additional file 1- Evaluation of PERFORM
system.
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